Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation.
- 1 October 1993
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 90 (19) , 8910-8914
- https://doi.org/10.1073/pnas.90.19.8910
Abstract
Androgen ablation induces programmed death of androgen-dependent prostatic glandular cells, resulting in fragmentation of their genomic DNA and the cells themselves into apoptotic bodies. Twenty percent of prostatic glandular cells undergo programmed death per day between day 2 and 5 after castration. During this same period, < 1% of prostatic glandular cells enter the S phase of the cell cycle, documenting that > 95% of these die in G0. During the programmed death of these G0 glandular cells, a futile DNA repair process is induced secondary to the DNA fragmentation. This futile DNA repair is not required, however, since inhibition of this process by > 90% with an appropriately timed hydroxy-urea dosing regimen had no effect upon the extent of the programmed death of these cells after castration. Likewise, p53 gene expression is not required since the same degree of cell death occurred in prostates and seminal vesicles after castration of wild-type and p53-deficient mice.Keywords
This publication has 40 references indexed in Scilit:
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- Castration‐induced changes in morphology, androgen levels, and proliferative activity of human prostate cancer tissue grown in athymic nude miceThe Prostate, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Tracer dose and availability time of thymidine and bromodeoxyuridine: application of bromodeoxyuridine in cell kinetic studiesCell Proliferation, 1990
- “Thymineless” death in androgen-independent prostatic cancer cellsBiochemical and Biophysical Research Communications, 1989
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis.The Journal of cell biology, 1988
- Calcium channel antagonists delay regression of androgen‐dependent tissues and suppress gene activity associated with cell deathThe Prostate, 1988
- Activation of a Ca2+−Mg2+‐dependent endonuclease as an early event in castration‐induced prostatic cell deathThe Prostate, 1988
- Cell proliferation studies in the rat prostate: II. The effects of castration and androgen‐induced regeneration upon basal and secretory cell proliferationThe Prostate, 1987